Evidence map›Paper›PMID 33009394›Full record

ArticleNature communications2020

Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p.

Mingyi Qu, Xiaojing Zou, Fang Fang, Shouye Wang, Lei Xu, Quan Zeng, Zeng Fan, Lin Chen, Wen Yue, Xiaoyan Xie and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 96 citations in OpenAlex.

  1. Platelet-derived microparticles induce CD8Experimental & molecular medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Bioengineering Platelets Presenting PD-L1, Galectin-9 and BTLA to Ameliorate Type 1 Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mingyi QuStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.ORCID http://orcid.org/0000-0002-0217-1386
Xiaojing ZouStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Fang FangStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Shouye WangStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Lei XuStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Quan ZengStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Zeng FanStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Lin ChenStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Wen YueStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China.
Xiaoyan XieStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China. xiex13@126.com.ORCID http://orcid.org/0000-0001-9728-457X
Xuetao PeiStem Cells and Regenerative Medicine Lab, Institute of Health Service and Transfusion Medicine Beijing, Beijing, 100850, China. peixt@bmi.ac.cn.
Center for High Pressure Science & Technology Advanced Research · CNBeijing Radiation Center · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombosis leads to platelet activation and subsequent degradation; therefore, replenishment of platelets from hematopoietic stem/progenitor cells (HSPCs) is needed to maintain the physiological level of circulating platelets. Platelet-derived microparticles (PMPs) are protein- and RNA-containing vesicles released from activated platelets. We hypothesized that factors carried by PMPs might influence the production of platelets from HSPCs, in a positive feedback fashion. Here we show that, during mouse acute liver injury, the density of megakaryocyte in the bone marrow increases following an increase in circulating PMPs, but without thrombopoietin (TPO) upregulation. In vitro, PMPs are internalized by HSPCs and drive them toward a megakaryocytic fate. Mechanistically, miR-1915-3p, a miRNA highly enriched in PMPs, is transported to target cells and suppresses the expression levels of Rho GTPase family member B, thereby inducing megakaryopoiesis. In addition, direct injection of PMPs into irradiated mice increases the number of megakaryocytes and platelets without affecting TPO levels. In conclusion, our data reveal that PMPs have a role in promoting megakaryocytic differentiation and platelet production.

Indexed as

Cell DifferentiationAnimalsBase SequenceBlood PlateletsCell-Derived MicroparticlesCell LineEndocytosisGene Expression ProfilingHumansLiverMaleMegakaryocytesMice, Inbred C57BLMice, TransgenicMicroRNAsPolyploidyMicroRNAsMIRN1915 microRNA, humanrhoB GTP-Binding ProteinRHOB protein, human

Identifiers

PMID33009394
PMCPMC7532443
OpenAlexW3091588921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.